Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 912-631-7 | CAS number: 12022-95-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: inhalation
Administrative data
- Endpoint:
- short-term repeated dose toxicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Range-finding study considering OECD 413, section: Range-finding study. Read-across to silicon.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Range-finding study conducted with silicon, considering OECD test guideline 413, section: Range-finding study
- GLP compliance:
- no
- Remarks:
- Study conducted in compliance with the principles of GLP, however no inspections by QAU staff were done
Test material
- Reference substance name:
- Silicon
- EC Number:
- 231-130-8
- EC Name:
- Silicon
- Cas Number:
- 7440-21-3
- Molecular formula:
- Si
- IUPAC Name:
- Silicon
- Test material form:
- aerosol dispenser: not specified
- Remarks:
- migrated information: aerosol
- Details on test material:
- - Name of test material (as cited in study report): Jetmilled Silgrain
- Physical state: Grey-brown powder
- Analytical purity: > 99.5% Si
:
- Lot/batch No.: J-257
- Expiration date of the lot/batch: Dec 13, 2018
- Storage condition of test material: Room temperature, at a dark place
- Other:
Particle size distribution: d10=1.3, d50=3, d90=7.4 (laser diffraction)
BET surface area 4.5-5.1 m2/g
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Diet (e.g. ad libitum): standard laboratory pellet diets, commercial chow in pellet form used, identified as ssniff "V1534", purchased from ssniff Spezialdiäten GmbH, Soest, Germany
- Water (e.g. ad libitum): tap water ad libidum
- Acclimation period: Rats exposed to the test item by nose-only inhalation. For a period of 2 - 3 weeks prior to exposure animals will be trained to become accustomed to nose-only tubes.
TEST ANIMALS
- Source: Wistar rats, strain Crl:WI (Han), purchased from Charles River Deutschland (Sulzfeld, Germany)
- Age at study initiation: approximately 8 weeks
- Weight at study initiation: males approximately 235 grams, females approximately 175 grams
- Fasting period before study: no
- Housing: Makrolon® (polycarbonate) cages type III, two rats per cage.Lignocel BK 8-15' absorbing softwood bedding material, changed twice a week or more often if necessary.
- Diet: commercial chow in pellet form: Ssniff "V1534", purchased from ssniff Spezialdiäten GmbH, Soest, Germany ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: The animals were first allowed to adjust and become acclimatized to the environment for one day. During 2-3 weeks prior to exposure start, all rats were trained to the 6-h restraint in nose-only tubes.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2 C
- Humidity (%): 55% ± 15%
- Photoperiod (hrs dark / hrs light): 12 h light/dark
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Remarks on MMAD:
- MMAD / GSD: MMAD approximately 2.4 µm.
- Details on inhalation exposure:
- - Exposure apparatus: The test item was administered to the test animals by nose-only inhalation, using a flow-past nose-only inhalation exposure system.
- Method of holding animals in test chamber: The rat nose is located at the front end of a tube being connected to a cylinder delivering the aerosol. Through the thin pipes, the aerosol was supplied to each rat nose individually and exhaled air was drawn off immediately by a cylinder surrounding the aerosol delivering cylinder.
The exposure tubed were arranged around a cylinder capable to take up 16 tubes per platform. The position of exposuretubes of tats at the cylinder was changed daily to minimize exposure differences due to geometry.
- System of generating particulates/aerosols: The particulate sample aerosols were generated by dispersing the dry powder. Dispersion was achieved by a feeding system and a high-pressure, high-velocity pressurized air dispersion nozzle. For each nose-exposure unit, the aaerosols were generated by a high-pressure pneumatic disperser, fed with the silicon powder under computerized control.
- Temperature, humidity, pressure in air chamber: 22° C + 2° C for temperature and 55 % + 15 % for relative humidity
- Air flow rate: laminar airflow to each rat of approximately 1 l/min - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The actual aerosol concentrations were measured daily using a photometer (gravimetric analysis of filter samples). The mean concentrations were very close to the target concentrations, being 3.83 mg/m3 in the 4 mg/m3-group, 20.03 mg/m3 in the 20 mg/m3-gropu and 101.81 mg/m3 in the 100 mg/m3 group.
- Duration of treatment / exposure:
- 2 weeks
- Frequency of treatment:
- 6 h/day, 5 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
4, 20 and 100mg/m3
Basis:
nominal conc.
- No. of animals per sex per dose:
- 10 animals/sex/dose in all groups except the 100 mg/m3 group having 15 animals/sex/dose.
- Control animals:
- yes
- Details on study design:
- - Rationale for animal assignment: The animals were allocated to groups based on body weight, in order to ensure that all animals in the groups had body weights deviating not more than approximately 20% from the mean weight of that group (male/female) at that time.
- No satellite groups. - Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: once per week
BODY WEIGHT: Yes
- Time schedule for examinations: thrice per week.
BRONCHOALVEOLAR LAVAGE (BAL):
- 5 males and 5 females per group on day 1 after the end of exposure.
- Macrophages, neutrophils, eosinophils and lymphocytes counted.
- LDH, B-glucuronidase and total protein measurements.
RETENTION ANALYSIS
-chemical analysis to verify the retention of silicon in the lungs and lung-associated lymph nodes. - Sacrifice and pathology:
- SACRIFICE
by an overdose of carbon dioxide. Rats scheduled for bronchoalveolar lavage sacrificed following a lethal narcosis using Narcoren.
HISTOPATHOLOGY: Yes
- 5 animals per group and sex at day 1 after the end of exposure.
- All animals of all groups: histopathology of lung lobes, including bronchi and the lung-associated lymph nodes, trachea, larynx, pharynx and the nasal cavities.
- Histopathological examination of other organs only if needed, e.g. as indicated by macroscopical findings - Statistics:
- Data analyzed using analysis of variance. Differences between groups considered statistically significant at p < 0.05.
The means of the treated groups were compared with the means of the control groups using Dunnett's test (if the group means differed significantly by the analysis of variance).
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Lung weight increased at 100 mg/m3
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- Very slight to sight (multi)focal alveolar accumulation of particle-laden macrophages were observed in all examined silicon-exposed animals.
Mild adverse effects were observed only in the 100 mg/m3 group: alveolar granulocyte infiltration and interstitial mononuclear cell infiltration.
Aggregates of particle-leaden macrophages were observed within the bronchus-associated lymphoid tissue in animals of the 20 mg/m3 and 100 mg/m3 groups.
Very slight to slight accumulation of particle-laden macrophages in the lung-associated lymph nodes was observed in the 20 mg/m3 and 100 mg/m3 groups.
BAL-fluid analyses showed increased levels of LDH and total protein in males and females exposed to 20 mg/m3 and 100 mg/m3 silicon. B-glucuronidase levels were increased in the 100 mg/m3 group. Cell counts showed increased amounts of macrophages and neutrophils in the samples of 20 mg/m3 and 100 mg/m3-exposed males and females. In addition, macrophages were induced in the 20 mg/m3 male rats, and in female and male rats exposed to 100 mg/m3.
The authors of the study report identified 4 mg/m3 silicon as a NOAEC for this study.
Effect levels
- Dose descriptor:
- NOAEC
- Effect level:
- 4 mg/m³ air (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: local lung effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Exposure to silicon particles via inhalation during 14 days resulted in mild, local, adverse effects only at the highest dose tested (100 m/m3). Bronchoalveolar-lavage fluid analysis showed silicon-exposure related, dose-dependent increases in lactate dehydrogenase, beta-glucuronidase and total protein concentrations. Also the concentration of leukocytes, macrophages and neutrophils incrreased upon exposure. No systemic effects were observed.
- Executive summary:
A 14-day nose-only inhalation study with silicon particles was performed by Fraunhofer ITEM in Wistar rats (Fraunhofer ITEM 2012). One aim of the study was to identify appropriate aerosol concentrations to be used in a subsequent 90-day inhalation study. Male and female rats were exposed to 4, 20 and 100 mg/m3of silicon particles (MMAD 2.6 µm), 5 days/week, 6 h/day during two weeks. No effects indicating systemic toxicity were observed at any doses. The lung weights were increased in animals of the high dose group at the end of the exposure period. Bronchoalveolar lavage fluid analyses showed dose-related effects in the 20 and 100 mg/m3groups. (Multi)focal alveolar accumulation of particle-laden macrophages was observed in animals of all groups. Furthermore, alveolar granulocyte infiltration and interstitial mononuclear cell infiltration were observed at 100 mg/m3. All observed effects were very slight or slight.
The NOAEC for silicon was 4 mg/m3and the LOAEC 20 mg/m3. On the basis of this study, a dosing scheme of 1, 4 and 16 mg/m3was proposed for the 90-day inhalation study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.